Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06196723
Status:
COMPLETED
Last Update Posted:
2024-03-08
First Post:
2023-12-25
Brief Title:
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
Sponsor:
Tang-Du Hospital
Organization:
Tang-Du Hospital
Study Overview
Official Title:
TIPS Improve Survival in Patients With Cirrhosis and Recurrent Ascites a Multicenter Observational Study
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TIPS
Brief Summary:
Currently there is limited evidence regarding the survival benefit of early transjugular intrahepatic portal shunt TIPS placement in patients with cirrhosis and recurrent ascites This observational study aimed to assess whether early TIPS improves the survival of patients with advanced cirrhosis and recurrent ascites We will compare large volume paracenteses plus albumin LVPA to see if TIPS improves the survival of patients with advanced cirrhosis and recurrent ascites
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None